An Observational Post-Authorisation Safety Study (PASS) of Patients with Chronic Opioid Use for Non-Cancer Pain and Cancer Pain who have Opioid-Induced Constipation (OIC) (Naldemedine PASS) First published 27/09/2021 Last updated 23/04/2024 EU PAS number:EUPAS43258 Study Planned